Cymbalta Users Urge Revival Of Drug's Withdrawal Claims
Three consumers accusing Eli Lilly & Co. of failing to warn them of the withdrawal risks of its antidepressant Cymbalta told the Ninth Circuit that a lower court erred in ruling...To view the full article, register now.
Already a subscriber? Click here to view full article